WA
GILD icon

Wheatland Advisors’s Gilead Sciences GILD Stock Holding History

Wheatland Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$746K Sell
9,700
-200
-2% -$15.3K 3.09% 10
2020
Q1 		$740K Sell
9,900
-6,745
-41% -$466K 3.76% 10
2019
Q4 		$1.08M Sell
16,645
-10,565
-39% -$688K 1.38% 27
2019
Q3 		$1.73M Sell
27,210
-7,950
-23% -$520K 1.57% 17
2019
Q2 		$2.38M Sell
35,160
-600
-2% -$39.5K 1.79% 18
2019
Q1 		$2.33M Buy
35,760
+1,400
+4% +$93.1K 1.77% 18
2018
Q4 		$2.15M Buy
34,360
+1,235
+4% +$86.3K 1.88% 18
2018
Q3 		$2.56M Buy
33,125
+1,075
+3% +$81.2K 1.92% 15
2018
Q2 		$2.27M Buy
32,050
+250
+0.8% +$17.7K 1.83% 18
2018
Q1 		$2.4M Buy
31,800
+500
+2% +$39.7K 1.98% 14
2017
Q4 		$2.24M Buy
31,300
+800
+3% +$60.8K 1.81% 19
2017
Q3 		$2.47M Buy
30,500
+125
+0.4% +$9.56K 2.11% 15
2017
Q2 		$2.15M Buy
+30,375
New +$2.02M 1.94% 18

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Wheatland Advisors's GILD Position: Q2 2020 in Review

Wheatland Advisors reduced its Gilead Sciences (GILD) stake by 2% in Q2 2020, selling an estimated $15.3K and leaving 9,700 shares worth $746K. The position accounts for 3.09% of the portfolio, ranked #10.

Wheatland Advisors first reported a position in GILD in Q2 2017 and has held it in 13 quarters since. The position peaked at $2.56M in Q3 2018. 1,625 funds tracked by Wall St. Rank hold GILD as of Q2 2020.

  • Wheatland Advisors held 9,700 shares of Gilead Sciences worth $746K as of Q2 2020.
  • Wheatland Advisors sold 200 Gilead Sciences shares in Q2 2020, an estimated $15.3K.
  • Gilead Sciences made up 3.09% of Wheatland Advisors's portfolio in Q2 2020, its #10 holding.
  • Wheatland Advisors first reported a position in Gilead Sciences in Q2 2017 and has held it in 13 quarters since.
  • Wheatland Advisors's Gilead Sciences position peaked at $2.56M in Q3 2018.
  • 1,625 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2020.

Based on Wheatland Advisors's 13F filing for Q2 2020, filed 28 Jul 2020.